This Week in Psychedelics - 1.27.17

  Image by  Dahtamnay , courtesy of  Creative Commons  licensing.

Image by Dahtamnay, courtesy of Creative Commons licensing.


  • Pot Protesters Welcome President Trump With 4,200 Joints (Reason)
  • Georgia eases draconian law on cannabis use (The Guardian)
  • Israel's Ariel University opens first academic course on medical cannabis (The Jerusalem Post)
  • NORML Chapters Organize State Lobby Days for Marijuana Law Reforms (NORML)
  • Maine Poised to Push Back Retail Cannabis Until 2018 (Leafly)
  • Cannabis and Epilepsy Treatment (Leafly)
  • Authorities seize 3,000 pounds of marijuana disguised as watermelons (CBS7)
  • Israel to fund research for medical cannabis crops (The Times of Israel)
  • Trump's AG Nominee Continues to Waffle on Cannabis (Leafly)
  • Using Veganics for Growing Organic Cannabis (Leafly)
  • Cannabis workshop educates on new program, future potential (The Guam Daily Post)
  • Texas Judge Says Teacher Shouldn't Be Disciplined for Consuming Cannabis in Colorado (Reason)
  • How Cannabis Became Illegal in Israel in the First Place (Haaretz)
  • Can You Trademark a Cannabis Brand? 'Stash' Case Offers Two Answers (Leafly)
  • Inside the #Trump420 Movement (TIME)
  • Cannabis Drug Company Zynerba Is Gearing Up For A Big Summer (Forbes)
  • Great-grandmother battles Ministry of Healthy over medicinal cannabis products (
  • High Hopes for the Legal Cannabis Industry (PR Newswire)


  • Ever Had a Really Long Acid Trip? Now Science Knows Why (WIRED)
  • The Micro-Dose vs. The Mystical Experience: Has LSD Turned its Back on the Psychedelic Revolution? (High Existence)
  • When Nixon's Henchmen Plotted to Assassinate a Journalist with LSD (The Daily Beast)
  • 'A Really Good Day' Recaps A Month-Long Adventure Of Microdosing LSD (NPR)
  • Here's how underground chemist Tim Scully planned to save the world with LSD (The Verge)
  • How Tripping On Acid Makes Music More Meaningful (Inverse)
  • Why I take LSD at work, a true story (Well+Good)

Psilocybin/Magic Mushrooms

  • How Microdosing Psilocybin May Keep Premenstrual Dysphoric Disorder (PMDD) at Bay (Psychedelic Times)
  • Magic Mushrooms Can Manage Anxiety And Depression In Cancer Patients; According To Research (iTech Post)



  • Tourist boom for ayahuasca a mixed blessing for Amazon (The Guardian)

Salvia Divinorum

  • Murder suspect Harris Binotti filmed losing control while flipping out on mindbending drugs (The Scottish Sun)


  • Researchers Build Multi-Regional Brain Chip to Study PCP's Effects on Brain (medGadget)
  • Taking ketamine 'could help alcoholics quit booze', experts claim (Metro)


  • Heroin injection sites may open soon in U.S. (Lancaster Online)
  • How Repealing Obamacare Could Impact the Drug Crisis (ATTN:)
  • The Story Behind the Viral Photo of an Opioid Overdose (TIME)
  • Recent deaths prompt state warning about carfentanil (Centre Daily Times)
  • Bill Maher: Heroin 'a Gateway to Being a Republican' (Rolling Stone)


  • America's war against opioid addiction - and the battle for kratom, the dietary supplement that has changed thousands of lives (The Telegraph)
  • Kratom: What We Know (Medscape)
  • Another blow to fighting opium addiction with the scheduling of Kratom (Psychedelic Press UK)


  • Santo kava farmers fear 'silent killer' investor threat to their production (Asia Pacific Report)
  • Board: Women's Kava Drinking Worrying (Fiji Sun)
  • Woman Clan Leader Says Men Also Abuse Kava (Fiji Sun)

Miscellaneous Psychedelics/Psychoactives/Drug Policy

  • BREAKING: Attorney General Vote Delayed (NORML)
  • How College "Psychedelic Clubs" are Changing the Conversation on Drugs (Leafly)
  • Monero, the Drug Dealer's Cryptocurrency of Choice, Is on Fire (WIRED)
  • Why psychedelic drugs are having a medical renaissance (PBS)
  • Pill testing sounds like a great idea, but there's a catch (The Age)
  • Better living through mushrooms (City Pulse)

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalogue how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.